Skip to main content

Table 2 Outcomes according to treatment assignment

From: Augmented-Medication CardioPulmonary Resuscitation Trials in out-of-hospital cardiac arrest: a pilot randomized controlled trial

 

Total (n = 148)

AMCPR (n = 74)

Placebo (n = 74)

Difference (%)

Relative risk (95% CI)

P

Primary outcome

Sustained ROSC

51 (34.5)

27 (36.5)

24 (32.4)

4.1

0.94 (0.74–1.19)

0.60

Secondary outcomes

Survival discharge

12 (8.1)

6 (8.1)

6 (8.1)

0

1.00 (0.91–1.10)

1.00

Good neurologic recoverya

0 (0.0)

0 (0.0)

0 (0.0)

0

1.00 (1.00–1.00)

1.00

  1. Data presented as the median (interquartile range)
  2. AMCPR Augmented-Medication of CardioPulmonary Resuscitation; ROSC return of spontaneous circulation; CI confidence interval
  3. aCerebral Performance Category 1 or 2 was considered a favorable outcome
Back to article page

Critical Care

ISSN: 1364-8535